LEVER: PHASE II TRIAL OF LEVONORGESTREL INTRAUTERINE DEVICE ALONE OR IN COMBINATION WITH THE MTORC1 INHIBITOR EVEROLIMUS FOR THE TREATMENT OF ATYPICAL ENDOMETRIAL HYPERPLASIA AND EARLY-STAGE ENDOMETRIAL CANCER